Literature DB >> 30116301

Acute uncomplicated cystitis: is antibiotic unavoidable?

Ekaterina Kulchavenya1.   

Abstract

BACKGROUND: Acute uncomplicated cystitis in women is one of the most frequently diagnosed bacterial infections.
METHODS: In a pilot, open, noncomparative prospective study, 29 nonpregnant, sexually active women with acute uncomplicated cystitis were enrolled. The mean age was 28.9 ± 4.3, range 22-36 years. All patients received unique therapy: the nonsteroidal anti-inflammatory drug (NSAID) ketoprofen, 100 mg once a day for 5 days, and Canephron, 2 dragees three times a day for 1 month.
RESULTS: In 2 days, four patients (13.8%) had no tendency to improvement; they were considered as nonresponders and antibiotics were prescribed for them. The remaining 25 patients (86.2%) showed significant improvement and were considered as responders; they continued the therapy with ketoprofen and Canephron. In 7 days, 21 patients (72.4%) had no dysuria and leucocyturia; they were considered as fast responders to phytotherapy. In four patients (13.8%), after 7 days of therapy insignificant dysuria and leucocyturia were found; they were considered as slow responders to phytotherapy. All 25 patients continued the intake of Canephron for 1 month to prevent a relapse. When treatment finished, all patients were well. In 6 months, no relapses were diagnosed.
CONCLUSION: The majority (86.2%) of young, nonpregnant women with acute uncomplicated cystitis were cured by 30 days of phytotherapy combined initially (5 days) with the NSAID ketoprofen; an antibiotic was indicated in only 13.8% of patients. Patients with acute uncomplicated cystitis may be divided into three subgroup: nonresponders to phytotherapy; slow responders to phytotherapy; fast responders to phytotherapy. Antibiotic therapy is indicated in nonresponders, but slow and fast responders may be treated without an antibiotic, by phytotherapy with an initial short course of an NSAID only.

Entities:  

Keywords:  acute cystitis; antibiotics; phytotherapy; urogenital tract infections

Year:  2018        PMID: 30116301      PMCID: PMC6088498          DOI: 10.1177/1756287218783644

Source DB:  PubMed          Journal:  Ther Adv Urol        ISSN: 1756-2872


  29 in total

1.  Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial.

Authors:  Jutta Bleidorn; Ildikó Gágyor; Michael M Kochen; Karl Wegscheider; Eva Hummers-Pradier
Journal:  BMC Med       Date:  2010-05-26       Impact factor: 8.775

Review 2.  The comeback of trimethoprim in France.

Authors:  F Caron; V Wehrle; M Etienne
Journal:  Med Mal Infect       Date:  2017-01-02       Impact factor: 2.152

3.  Antimicrobial susceptibility of pathogens in acute uncomplicated cystitis cases in the urology department of a community hospital in Japan: Comparison with treatment outcome and hospital-wide antibiogram.

Authors:  Toshiki Etani; Taku Naiki; Sachiyo Yamaguchi; Saori Mori; Takashi Nagai; Keitaro Iida; Ryosuke Ando; Noriyasu Kawai; Keiichi Tozawa; Tohru Mogami; Takahiro Yasui
Journal:  J Infect Chemother       Date:  2017-08-12       Impact factor: 2.211

4.  [Are there alternatives to antimicrobial therapy and prophylaxis of uncomplicated urinary tract infections?]

Authors:  K G Naber; J F Alidjanov
Journal:  Urologiia       Date:  2016-08

5.  [Causative Bacterial Strains and Sensitivityto Antimicrobial Agents in Female Acute Uncomplicated Cystitis].

Authors:  Takuya Owari; Tomoki Yamamoto; Shinichiro Mizobuchi; Yositaka Itami; Tomonori Nakahama; Yosihiro Matsumoto; Kaoru Yamada; Hitoshi Momose
Journal:  Hinyokika Kiyo       Date:  2017-05

6.  Preferential Use of Nitrofurantoin Over Fluoroquinolones for Acute Uncomplicated Cystitis and Outpatient Escherichia coli Resistance in an Integrated Healthcare System.

Authors:  Rebecca L Pedela; Katherine C Shihadeh; Bryan C Knepper; Michelle K Haas; William J Burman; Timothy C Jenkins
Journal:  Infect Control Hosp Epidemiol       Date:  2017-01-05       Impact factor: 3.254

7.  Effect of the herbal combination Canephron N on diabetic nephropathy in patients with diabetes mellitus: results of a comparative cohort study.

Authors:  Liliya Martynyuk; Larysa Martynyuk; Oksana Ruzhitska; Olena Martynyuk
Journal:  J Altern Complement Med       Date:  2014-04-16       Impact factor: 2.579

8.  [Features of the incidence of cystitis depending on the type of contraception].

Authors:  E V Kulchavenia; E V Brizhatiuk; V T Khomiakov; A A Breusov
Journal:  Urologiia       Date:  2013 Jan-Feb

9.  Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: review of clinical experience in Eastern Europe and Central Asia.

Authors:  Kurt G Naber
Journal:  Res Rep Urol       Date:  2013-02-04

10.  Ibuprofen versus mecillinam for uncomplicated cystitis--a randomized controlled trial study protocol.

Authors:  Ingvild Vik; Marianne Bollestad; Nils Grude; Anders Bærheim; Sigvard Mölstad; Lars Bjerrum; Morten Lindbæk
Journal:  BMC Infect Dis       Date:  2014-12-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.